| scholarly article | Q13442814 |
| P2093 | author name string | Rory R Koenen | |
| Rafael Kramann | |||
| Leon J Schurgers | |||
| Maurice Halder | |||
| Asim C Akbulut | |||
| Dawid M Kaczor | |||
| P2860 | cites work | Platelet-mediated modulation of adaptive immunity: unique delivery of CD154 signal by platelet-derived membrane vesicles | Q24655248 |
| Electron microscopic studies of induced cartilage development and calcification | Q24682867 | ||
| Extracellular vesicles as mediators of vascular inflammation in kidney disease | Q26765072 | ||
| Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes | Q27317206 | ||
| Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells | Q27860960 | ||
| The biology of extracellular vesicles with focus on platelet microparticles and their role in cancer development and progression | Q28066054 | ||
| Transfusion as an Inflammation Hit: Knowns and Unknowns | Q28074933 | ||
| A perivascular origin for mesenchymal stem cells in multiple human organs | Q28131808 | ||
| Circulating procoagulant microparticles and soluble GPV in myocardial infarction treated by primary percutaneous transluminal coronary angioplasty. A possible role for GPIIb-IIIa antagonists | Q28169115 | ||
| Elevated numbers of tissue-factor exposing microparticles correlate with components of the metabolic syndrome in uncomplicated type 2 diabetes mellitus | Q44205749 | ||
| Activated platelets can deliver mRNA regulatory Ago2•microRNA complexes to endothelial cells via microparticles | Q44791838 | ||
| Characterization of a novel bleeding disorder with isolated prolonged bleeding time and deficiency of platelet microvesicle generation | Q45880868 | ||
| The effects of pitavastatin, eicosapentaenoic acid and combined therapy on platelet-derived microparticles and adiponectin in hyperlipidemic, diabetic patients | Q46145116 | ||
| MicroRNA-205 regulates the calcification and osteoblastic differentiation of vascular smooth muscle cells | Q46284267 | ||
| Platelet microparticles and soluble P selectin in peripheral artery disease: relationship to extent of disease and platelet activation markers | Q46498134 | ||
| Microparticle increase in severe obesity: not related to metabolic syndrome and unchanged after massive weight loss | Q46630599 | ||
| The pericyte as a possible osteoblast progenitor cell. | Q46834781 | ||
| Pericytes resident in postnatal skeletal muscle differentiate into muscle fibres and generate satellite cells | Q46899831 | ||
| Elevated levels of remnant lipoproteins are associated with plasma platelet microparticles in patients with type-2 diabetes mellitus without obstructive coronary artery disease | Q46909923 | ||
| Impact of weight reduction on production of platelet-derived microparticles and fibrinolytic parameters in obesity. | Q47349504 | ||
| Matrix vesicles induce calcification of recipient vascular smooth muscle cells through multiple signaling pathways | Q47651359 | ||
| Vascular Smooth Muscle Cells and Arterial Stiffening: Relevance in Development, Aging, and Disease | Q47734987 | ||
| Differential Expression of microRNAs in Severely Calcified Carotid Plaques | Q49917413 | ||
| MiR-26a regulates vascular smooth muscle cell calcification in vitro through targeting CTGF. | Q50098236 | ||
| Microvesicles in vascular homeostasis and diseases. Position Paper of the European Society of Cardiology (ESC) Working Group on Atherosclerosis and Vascular Biology | Q50205919 | ||
| Platelet activation and reactivity in the convalescent phase of ischaemic stroke | Q50275282 | ||
| MiR-135a Suppresses Calcification in Senescent VSMCs by Regulating KLF4/STAT3 Pathway. | Q50333234 | ||
| Sortilin mediates vascular calcification via its recruitment into extracellular vesicles | Q28273951 | ||
| Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein | Q28304798 | ||
| Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs | Q28941769 | ||
| Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules | Q29614240 | ||
| Molecular regulation of vascular smooth muscle cell differentiation in development and disease | Q29615194 | ||
| Annexins: from structure to function | Q29616171 | ||
| Extracellular vesicles: exosomes, microvesicles, and friends | Q29618137 | ||
| KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis | Q30299921 | ||
| Epigenetic control of smooth muscle cell differentiation and phenotypic switching in vascular development and disease | Q30454529 | ||
| Megakaryocyte-derived microparticles: direct visualization and distinction from platelet-derived microparticles | Q30485800 | ||
| High-shear-stress-induced activation of platelets and microparticles enhances expression of cell adhesion molecules in THP-1 and endothelial cells | Q31013634 | ||
| Decreased responsiveness and development of activation markers of PLTs stored in plasma | Q33358329 | ||
| Extracellular vesicles in cardiovascular disease: are they Jedi or Sith? | Q33362561 | ||
| Embryonic origins of human vascular smooth muscle cells: implications for in vitro modeling and clinical application | Q33651561 | ||
| Parathyroid hormone: critical bridge between bone metabolism and cardiovascular disease. | Q33889235 | ||
| Existence of a microRNA pathway in anucleate platelets | Q34025954 | ||
| Kidney pericytes: roles in regeneration and fibrosis. | Q34176024 | ||
| A pericyte origin of spinal cord scar tissue | Q34198591 | ||
| Inorganic phosphate accelerates the migration of vascular smooth muscle cells: evidence for the involvement of miR-223. | Q34456584 | ||
| Deciphering the human platelet sheddome. | Q34568946 | ||
| Decreased microRNA is involved in the vascular remodeling abnormalities in chronic kidney disease (CKD). | Q34746039 | ||
| Perivascular Gli1+ progenitors are key contributors to injury-induced organ fibrosis. | Q34899171 | ||
| Heterogeneity in vascular smooth muscle cell embryonic origin in relation to adult structure, physiology, and disease | Q35132388 | ||
| Calcium Overload - An Important Cellular Mechanism in Hypertension and Arteriosclerosis | Q35166903 | ||
| Microparticles from apoptotic platelets promote resident macrophage differentiation. | Q35269888 | ||
| Osteogenic regulation of vascular calcification: an early perspective | Q35753562 | ||
| Microparticles: major transport vehicles for distinct microRNAs in circulation | Q35792749 | ||
| Runx2/miR-3960/miR-2861 Positive Feedback Loop Is Responsible for Osteogenic Transdifferentiation of Vascular Smooth Muscle Cells | Q35843150 | ||
| The tunica adventitia of human arteries and veins as a source of mesenchymal stem cells. | Q35964777 | ||
| Endothelial Cells Can Regulate Smooth Muscle Cells in Contractile Phenotype through the miR-206/ARF6&NCX1/Exosome Axis | Q35975556 | ||
| Pharmacological GLI2 inhibition prevents myofibroblast cell-cycle progression and reduces kidney fibrosis | Q36040432 | ||
| Platelets and platelet-like particles mediate intercellular RNA transfer | Q36058568 | ||
| The release of vesicles from platelets following adhesion to vessel walls in vitro | Q36130229 | ||
| Role of the membrane skeleton in preventing the shedding of procoagulant-rich microvesicles from the platelet plasma membrane | Q36223464 | ||
| Regulated production of mineralization-competent matrix vesicles in hypertrophic chondrocytes | Q36262059 | ||
| Smooth muscle phenotypic changes in arterial wall homeostasis: implications for the pathogenesis of atherosclerosis | Q39816392 | ||
| Exosomes in human atherosclerosis: An ultrastructural analysis study | Q39875526 | ||
| Bone morphogenetic protein expression in human atherosclerotic lesions. | Q40304303 | ||
| Platelet microparticles: a transcellular delivery system for RANTES promoting monocyte recruitment on endothelium | Q40423150 | ||
| Platelet-derived microparticles stimulate proliferation, survival, adhesion, and chemotaxis of hematopoietic cells | Q40729733 | ||
| MicroRNA-297a regulates vascular calcification by targeting fibroblast growth factor 23. | Q40967549 | ||
| Multivesicular bodies are an intermediate stage in the formation of platelet alpha-granules. | Q41050738 | ||
| Different Potential of Extracellular Vesicles to Support Thrombin Generation: Contributions of Phosphatidylserine, Tissue Factor, and Cellular Origin | Q41141303 | ||
| White fat progenitor cells reside in the adipose vasculature. | Q41145314 | ||
| Proteomic analysis reveals presence of platelet microparticles in endothelial progenitor cell cultures | Q41394331 | ||
| Smooth muscle cell heterogeneity: patterns of gene expression in vascular smooth muscle cells in vitro and in vivo | Q41726539 | ||
| miRNA-221 and miRNA-222 synergistically function to promote vascular calcification. | Q42084206 | ||
| Bone morphogenetic protein-2 decreases microRNA-30b and microRNA-30c to promote vascular smooth muscle cell calcification | Q42114732 | ||
| Platelets activated during myocardial infarction release functional miRNA, which can be taken up by endothelial cells and regulate ICAM1 expression. | Q42773654 | ||
| Platelet-derived exosomes induce endothelial cell apoptosis through peroxynitrite generation: experimental evidence for a novel mechanism of septic vascular dysfunction | Q43029801 | ||
| Annexin-mediated matrix vesicle calcification in vascular smooth muscle cells | Q43123560 | ||
| Type 1 and type 2 diabetic patients display different patterns of cellular microparticles | Q44114915 | ||
| Gli1+ Mesenchymal Stromal Cells Are a Key Driver of Bone Marrow Fibrosis and an Important Cellular Therapeutic Target. | Q50650313 | ||
| The prowess of platelets in immunity and inflammation. | Q50793769 | ||
| Lipid-lowering therapy with statins reduces microparticle shedding from endothelium, platelets and inflammatory cells. | Q50933443 | ||
| Vitamin K: key vitamin in controlling vascular calcification in chronic kidney disease. | Q51028433 | ||
| Prothrombin Loading of Vascular Smooth Muscle Cell-Derived Exosomes Regulates Coagulation and Calcification. | Q51037169 | ||
| MicroRNA-34b/c inhibits aldosterone-induced vascular smooth muscle cell calcification via a SATB2/Runx2 pathway. | Q51583712 | ||
| MicroRNAs that target Ca(2+) transporters are involved in vascular smooth muscle cell calcification. | Q52626347 | ||
| Vascular smooth muscle cell calcification is mediated by regulated exosome secretion. | Q52964505 | ||
| Elevated platelet microparticles in transient ischemic attacks, lacunar infarcts, and multiinfarct dementias. | Q53208395 | ||
| Circulating microparticle signature in coronary and peripheral blood of ST elevation myocardial infarction patients in relation to pain-to-PCI elapsed time. | Q53328449 | ||
| Platelet microparticles reprogram macrophage gene expression and function. | Q53358769 | ||
| Exosomes Derived from Human Pulmonary Artery Endothelial Cells Shift the Balance between Proliferation and Apoptosis of Smooth Muscle Cells. | Q53754591 | ||
| Post-translational modifications regulate matrix Gla protein function: importance for inhibition of vascular smooth muscle cell calcification. | Q54162736 | ||
| Microvesicles from platelets: novel drivers of vascular inflammation | Q57574568 | ||
| Factors influencing the level of circulating procoagulant microparticles in acute pulmonary embolism | Q58148911 | ||
| Cellular Origins and Thrombogenic Activity of Microparticles Isolated From Human Atherosclerotic Plaques | Q58149183 | ||
| Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets | Q58487090 | ||
| High levels of TSP1+/CD142+ platelet-derived microparticles characterise young patients with high cardiovascular risk and subclinical atherosclerosis | Q60651837 | ||
| P-Selectin- and CD63-Exposing Platelet Microparticles Reflect Platelet Activation in Peripheral Arterial Disease and Myocardial Infarction | Q62977663 | ||
| Matrix vesicles in atherosclerotic calcification | Q71671852 | ||
| The Nature and Significance of Platelet Products in Human Plasma | Q72220665 | ||
| Platelet microparticles and calcium homeostasis in acute coronary ischemias | Q73075680 | ||
| Enzyme immunoassay detection of platelet-derived microparticles and RANTES in acute coronary syndrome | Q73096062 | ||
| P-Selectin expression, platelet aggregates, and platelet-derived microparticle formation are increased in peripheral arterial disease | Q73333604 | ||
| Leukocyte-leukocyte interactions mediated by platelet microparticles under flow | Q73426888 | ||
| Platelet-derived microparticles in patients with arteriosclerosis obliterans: enhancement of high shear-induced microparticle generation by cytokines | Q73815958 | ||
| Vimentin exposed on activated platelets and platelet microparticles localizes vitronectin and plasminogen activator inhibitor complexes on their surface | Q77355818 | ||
| Effects of severe hypertension on endothelial and platelet microparticles | Q78945402 | ||
| Clinically apparent atherosclerotic disease in diabetes is associated with an increase in platelet microparticle levels | Q82212860 | ||
| D-dimer, P-selectin, and microparticles: novel markers to predict deep venous thrombosis. A pilot study | Q82256250 | ||
| Elevated levels of platelet microparticles in carotid atherosclerosis and during the postprandial state | Q82919809 | ||
| Microparticles (ectosomes) shed by stored human platelets downregulate macrophages and modify the development of dendritic cells | Q83985201 | ||
| Plasma level of platelet-derived microparticles is associated with coronary heart disease risk score in healthy men | Q84028329 | ||
| Atorvastatin reduces thrombin generation and expression of tissue factor, P-selectin and GPIIIa on platelet-derived microparticles in patients with peripheral arterial occlusive disease | Q84198879 | ||
| Evaluation of factors associated with elevated levels of platelet-derived microparticles in the acute phase of cerebral infarction | Q84387384 | ||
| Increased platelet, leukocyte and endothelial microparticles predict enhanced coagulation and vascular inflammation in pulmonary hypertension | Q84641191 | ||
| MicroRNA-204 regulates vascular smooth muscle cell calcification in vitro and in vivo | Q84748376 | ||
| Increased levels of platelet activation markers are positively associated with carotid wall thickness and other atherosclerotic risk factors in obese patients | Q84820508 | ||
| MicroRNA-32 promotes calcification in vascular smooth muscle cells: Implications as a novel marker for coronary artery calcification | Q36314694 | ||
| Differentiation of multipotent vascular stem cells contributes to vascular diseases | Q36511596 | ||
| MicroRNAs 29b, 133b, and 211 Regulate Vascular Smooth Muscle Calcification Mediated by High Phosphorus | Q36624625 | ||
| A sonic hedgehog signaling domain in the arterial adventitia supports resident Sca1+ smooth muscle progenitor cells | Q36756907 | ||
| The vascular biology of calcification. | Q36764999 | ||
| MicroRNA in cardiovascular calcification: focus on targets and extracellular vesicle delivery mechanisms. | Q36890424 | ||
| Endothelial dysfunction caused by circulating microparticles from patients with metabolic syndrome. | Q36891589 | ||
| Characterization of blood borne microparticles as markers of premature coronary calcification in newly menopausal women | Q36893365 | ||
| Macrophage-derived matrix vesicles: an alternative novel mechanism for microcalcification in atherosclerotic plaques | Q36990315 | ||
| Follicular dendritic cells emerge from ubiquitous perivascular precursors | Q36991851 | ||
| Transdifferentiation of mouse aortic smooth muscle cells to a macrophage-like state after cholesterol loading | Q37089500 | ||
| Role of extracellular vesicles in de novo mineralization: an additional novel mechanism of cardiovascular calcification | Q37210903 | ||
| Modulation of monocyte-endothelial cell interactions by platelet microparticles | Q37387105 | ||
| Function, Role, and Clinical Application of MicroRNAs in Vascular Aging | Q37554078 | ||
| Down-regulation of miR-96 by bone morphogenetic protein signaling is critical for vascular smooth muscle cell phenotype modulation | Q37562000 | ||
| Microparticles: protagonists of a novel communication network for intercellular information exchange | Q37804649 | ||
| Platelet-derived microvesicles: multitalented participants in intercellular communication | Q37982277 | ||
| The vascular smooth muscle cell in arterial pathology: a cell that can take on multiple roles | Q37998958 | ||
| Vascular calcification: the price to pay for anticoagulation therapy with vitamin K-antagonists | Q38004150 | ||
| Vitamin K-dependent carboxylation of matrix Gla-protein: a crucial switch to control ectopic mineralization | Q38078666 | ||
| Origins of fibrosis: pericytes take centre stage | Q38139402 | ||
| MiR-133a modulates osteogenic differentiation of vascular smooth muscle cells | Q38314602 | ||
| miR-125b regulates calcification of vascular smooth muscle cells | Q38575745 | ||
| Platelet-derived Extracellular Vesicles: An Emerging Therapeutic Approach. | Q38642475 | ||
| Platelet extracellular vesicles induce a pro-inflammatory smooth muscle cell phenotype. | Q38674677 | ||
| An overview of potential molecular mechanisms involved in VSMC phenotypic modulation | Q38680594 | ||
| Introduction to Extracellular Vesicles: Biogenesis, RNA Cargo Selection, Content, Release, and Uptake | Q38800211 | ||
| MiR-29-mediated elastin down-regulation contributes to inorganic phosphorus-induced osteoblastic differentiation in vascular smooth muscle cells | Q38816363 | ||
| The roles of RNA processing in translating genotype to phenotype | Q39009636 | ||
| Platelet microvesicles in health and disease | Q39094993 | ||
| Extracellular vesicles and blood diseases | Q39107240 | ||
| Extracellular vesicles in coronary artery disease. | Q39115035 | ||
| Contribution of platelet CX(3)CR1 to platelet-monocyte complex formation and vascular recruitment during hyperlipidemia | Q39387096 | ||
| Adventitial MSC-like Cells Are Progenitors of Vascular Smooth Muscle Cells and Drive Vascular Calcification in Chronic Kidney Disease | Q39401060 | ||
| Platelet microparticles are heterogeneous and highly dependent on the activation mechanism: studies using a new digital flow cytometer | Q39781488 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | extracellular vesicle | Q21097485 |
| vascular calcification | Q54911504 | ||
| P304 | page(s) | 36 | |
| P577 | publication date | 2018-04-06 | |
| P1433 | published in | Frontiers in cardiovascular medicine | Q27726930 |
| P1476 | title | Initiation and Propagation of Vascular Calcification Is Regulated by a Concert of Platelet- and Smooth Muscle Cell-Derived Extracellular Vesicles. | |
| P478 | volume | 5 |
| Q64072006 | Coronary artery calcium testing: A call for universal coverage |
| Q92663075 | Hypoxia-Inducible Factor-1α: The Master Regulator of Endothelial Cell Senescence in Vascular Aging |
| Q94527020 | Microvesicles from indoxyl sulfate-treated endothelial cells induce vascular calcification in vitro |
| Q60938171 | Roles and Regulation of Extracellular Vesicles in Cardiovascular Mineral Metabolism |
| Q94528610 | Targeting Vascular Calcification in Chronic Kidney Disease |
| Q64260169 | Vitamin K: Double Bonds beyond Coagulation Insights into Differences between Vitamin K1 and K2 in Health and Disease |
Search more.